Company: LIMN
Filing Date: 2025-07-28
Form Type: S-1/A
Source: 0001410578-25-001518
Chunk: 109

Company: Liminatus Pharma, Inc.
Filing Date: 2025-07-28
Form: S-1/A
Chunk 109
---
 |        |   |     | ​ |           |            |
| Basic and diluted weighted average shares outstanding                  | ​ |              |            | ​ |              |           | ​ |              |       | ​ |             |        |   |     | ​ |           | 26,714,633 |
| Basic and diluted net income (loss) per share                          | ​ |              |            | ​ |              |           | ​ |              |       | ​ |             |        |   |     | ​ | $         |      -0.11 |

69

UNAUDITED PRO FORMA COMBINED STATEMENT OF OPERATIONS FOR THE YEAR ENDED DECEMBER 31, 2024 (Dollars In Thousands, Except Share and Per Share Amounts)

| ​                                                                      
 Operating expenses:                                                    | ​ 
 ​ 
 ​ 
 ​ | ​            
 ​            
 Liminatus    
 (Historical) 
 ​            |            | ​ 
 ​ 
 ​ 
 ​ | ​            
 ​            
 Iris         
 (Historical) 
 ​            |           | ​ 
 ​ 
 ​ 
 ​ | ​            
 ​            
 ParentCo     
 (Historical) 
 ​            |       | ​ 
 ​ 
 ​ 
 ​ | ​           
 Transaction 
 Accounting  
 Adjustments 
 ​           |        | ​ 
 ​ 
 ​ 
 ​ | ​   | ​ 
 ​ 
 ​ 
 ​ | ​         
 ​         
 Pro Forma 
 Combined  
 ​         |            |
|:-----------------------------------------------------------------------|:--|:-------------|-----------:|:--|:-------------|----------:|:--|:-------------|------:|:--|:------------|-------:|:--|:----|:--|:----------|-----------:|
| General and administrative                                             | ​ | $            |        645 | ​ | $            |     2,906 | ​ | $            |     — | ​ | ​           |        | ​ |     | ​ | $         |      3,551 |
| Research and development                                               | ​ | ​            |      2,685 | ​ | ​            |         — | ​ | ​            |     — | ​ | ​           |        | ​ |     | ​ | ​         |      2,685 |
| Total operating expenses                                               | ​ | ​            |      3,330 | ​ | ​            |     2,906 | ​ | ​            |     — | ​ | ​           |      — | ​ |